Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
Ian Gilron
1
, MSc, MD ;
Dongsheng Tu
2
, PhD ;
Ronald Holden
2
, PhD ;
Tanveer Towheed
2
, MD ;
Elizabeth Vandenkerkhof
2
, DrPH ;
Roumen Milev
2
, MD, PhD
1
Queen's University, Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, ON, Canada
2
Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada
Corresponding Author:
-
Ian Gilron, MSc, MD
-
Queen's University
-
Department of Anesthesiology and Perioperative Medicine
-
Queen's University
-
Kingston General Hospital
-
76 Stuart Street, Victory 2 Pavillion
-
Kingston, ON
-
Canada
-
Phone:
1 613 549 6666 ext 3963
-
Fax: 1 613 548 1375
-
Email: gilroni@queensu.ca